journal article·2016-04

Development of a long-acting, protein-loaded, redox-active, injectable gel formed by a polyion complex for local protein therapeutics

Shiro Ishii, Junya Kaneko, Yukio Nagasaki

Biomaterials· Volume 84
Publisher page

Abstract

Although cancer immunotherapies are attracting much attention, it is difficult to develop bioactive proteins owing to the severe systemic toxicity. To overcome the issue, we designed new local protein delivery system by using a protein-loaded, redox-active, injectable gel (RIG), which is formed by a polyion complex (PIC) comprising three components, viz., cationic polyamine-poly(ethylene glycol)-polyamine triblock copolymer possessing ROS-scavenging moieties as side chains; anionic poly(acrylic acid); and a protein. The mixture formed the protein-loaded PIC flower micelles at room temperature, which immediately converted to a gel with high mechanical strength upon exposure to physiological conditions. Because the protein electrostatically interacts with the PIC gel network, RIG provided a sustained release of the protein without a significant initial burst, regardless of the types of proteins in vitro, and much longer retention of the protein at the local injection site in mice than that of the naked protein. Subcutaneous injections of IL-12@RIG in the vicinity of tumor tissue showed remarkable tumor growth inhibition in tumor-bearing mice, compared to that observed with injection of IL-12 alone, suppressing adverse events caused by IL-12-induced ROS. Our results indicate that RIG has potential as a platform technology for an injectable sustained-release carrier for proteins.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Glycosylation and Glycoproteins Research · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (33)

Show source-provided references
1. Clinical-trials – IL-12 deaths – Explanation and a puzzle10.1126/science.270.5238.908.a ↗
2. Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy10.1200/JCO.1995.13.3.688 ↗
3. Kaposi's sarcoma and the acquired immunodeficiency syndrome: treatment with high and low doses of recombinant leukocyte A interferon10.1200/JCO.1986.4.4.544 ↗
4. TReatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 210.1001/jama.1994.03510360033032 ↗
5. Immune checkpoint blockade in cancer treatment: a double-edged sword cross-targeting the host as an “innocent bystander”10.3390/toxins6030914 ↗
6. Interleukin-12 and the regulation of innate resistance and adaptive immunity10.1038/nri1001 ↗
7. Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production
8. The toxicology of interleukin-12: a review10.1177/019262339902700112 ↗
9. THE Stimulatory effects of interleukin (il)-12 on hematopoiesis are antagonized by il-12-induced interferon-gamma in-vivo10.1084/jem.181.5.1893 ↗
10. Interferon-gamma induces reactive oxygen species and endoplasmic reticulum stress at the hepatic apoptosis10.1002/jcb.10501 ↗
11. Mechanisms of liver injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways10.1152/ajpgi.00422.2005 ↗
12. Superoxide accelerates DNA damage by elevating free-iron levels10.1073/pnas.93.24.13635 ↗
13. Nanogel DDS enables sustained release of IL-12 for tumor immunotherapy10.1016/j.bbrc.2007.12.112 ↗
14. A novel method for viral gene delivery in solid tumors10.1158/0008-5472.CAN-05-1112 ↗
15. Engineered in-situ depot-forming hydrogels for intratumoral drug delivery10.1016/j.jconrel.2015.11.014 ↗
16. Role of chitosan co-formulation in enhancing interleukin-12 delivery and antitumor activity10.1016/j.biomaterials.2013.02.031 ↗
17. Aptamer-functionalized in situ injectable hydrogel for controlled protein release10.1021/bm100774t ↗
18. Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers10.1016/j.jconrel.2011.11.031 ↗
19. Injectable hydrogels as unique biomedical materials10.1039/b713009k ↗
20. Injectable implants for the sustained release of protein and peptide drugs10.1016/j.drudis.2013.01.013 ↗
21. In situ gelling pH- and temperature-sensitive biodegradable block copolymer hydrogels for drug delivery10.1016/j.jconrel.2014.04.056 ↗
22. Injectable hydrogels from triblock copolymers of vitamin E-functionalized polycarbonate and poly(ethylene glycol) for subcutaneous delivery of antibodies for cancer therapy10.1002/adfm.201301307 ↗
23. Synthesis, characterization, biodegradability and biocompatibility of a temperature-sensitive PBLA-PEG-PBLA hydrogel as protein delivery system with low critical gelation concentration10.3109/03639045.2013.814066 ↗
24. Thermoreversible gelation behaviour of PTMC-PEG-PTMC triblock copolymers10.1016/j.jconrel.2008.09.024 ↗
25. Control of blood glucose by novel GLP-1 delivery using biodegradable triblock copolymer of PLGA-PEG-PLGA in type 2 diabetic rats10.1023/B:PHAM.0000026435.27086.94 ↗
26. Controlled release of insulin from injectable biodegradable triblock copolymer depot in ZDF rats10.1023/B:PHAM.0000008050.99985.5c ↗
27. Dual stimuli-responsive redox-active injectable gel by polyion complex based flower micelles for biomedical applications10.1021/acs.macromol.5b00305 ↗
28. Redox-active injectable gel using thermo-responsive nanoscale polyion complex flower micelle for noninvasive treatment of local inflammation10.1016/j.jconrel.2013.10.009 ↗
29. Design of high-performance anti-adhesion agent using injectable gel with an anti-oxidative stress function10.1016/j.biomaterials.2015.08.018 ↗
30. Stimuli-induced multiple sol−gel−sol transitions of aqueous solution of a thermo- and light-sensitive hydrophilic block copolymer10.1021/ma9015906 ↗
31. Non-linear effects in the quenching of fluorescent quantum dots by nitroxyl free radicals10.1039/B511515A ↗
32. Non-linear effects in the quenching of fluorescent semiconductor nanoparticles by paramagnetic species10.1002/pssa.200566186 ↗
33. Stabilization of lysozyme-incorporated polyion complex micelles by the ω-end derivatization of poly(ethylene glycol)−poly(α,β-aspartic acid) block copolymers with hydrophobic groups10.1021/la0488811 ↗